CN105461776B - 一种黄体酮的合成方法 - Google Patents
一种黄体酮的合成方法 Download PDFInfo
- Publication number
- CN105461776B CN105461776B CN201510715996.9A CN201510715996A CN105461776B CN 105461776 B CN105461776 B CN 105461776B CN 201510715996 A CN201510715996 A CN 201510715996A CN 105461776 B CN105461776 B CN 105461776B
- Authority
- CN
- China
- Prior art keywords
- ether
- reaction
- synthetic method
- solvent
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title claims abstract description 42
- 229960003387 progesterone Drugs 0.000 title claims abstract description 21
- 239000000186 progesterone Substances 0.000 title claims abstract description 21
- 238000010189 synthetic method Methods 0.000 title claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 4
- 238000006114 decarboxylation reaction Methods 0.000 claims abstract description 3
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 20
- GAWAYYRQGQZKCR-UHFFFAOYSA-N 2-chloropropionic acid Chemical class CC(Cl)C(O)=O GAWAYYRQGQZKCR-UHFFFAOYSA-N 0.000 claims description 10
- 239000004593 Epoxy Substances 0.000 claims description 10
- 125000004494 ethyl ester group Chemical group 0.000 claims description 9
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- -1 dimethyl methyl Chemical group 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000012065 filter cake Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 10
- 238000003786 synthesis reaction Methods 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000007613 environmental effect Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000011261 inert gas Substances 0.000 abstract description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- VKSJVMZEQNIBNA-UHFFFAOYSA-N 2-chloroethyl propanoate Chemical compound CCC(=O)OCCCl VKSJVMZEQNIBNA-UHFFFAOYSA-N 0.000 abstract 1
- 238000007259 addition reaction Methods 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229960005471 androstenedione Drugs 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 235000004360 Dioscorea zingiberensis Nutrition 0.000 description 2
- 241001678283 Dioscorea zingiberensis Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 210000004246 corpus luteum Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- KMVFFAJEZSJICZ-UHFFFAOYSA-N CC(C(CC(C1C(C)(CC2)C(C(C)=O)=CC1)C2C1(C)CC2)C1=CC2=O)O Chemical compound CC(C(CC(C1C(C)(CC2)C(C(C)=O)=CC1)C2C1(C)CC2)C1=CC2=O)O KMVFFAJEZSJICZ-UHFFFAOYSA-N 0.000 description 1
- IKBHNNMXKFPLQG-UHFFFAOYSA-N CCC1(CCC(OCC)=C2)C2=CCC(C2CC3)C1CCC2(C)C3=O Chemical compound CCC1(CCC(OCC)=C2)C2=CCC(C2CC3)C1CCC2(C)C3=O IKBHNNMXKFPLQG-UHFFFAOYSA-N 0.000 description 1
- NKCCRSFPYWZCQB-UHFFFAOYSA-N CCOC(C1(C)OC1(CC1)C(C)(CC2)C1C1C2C(C)(CCC(OCC)=C2)C2=CC1)=O Chemical compound CCOC(C1(C)OC1(CC1)C(C)(CC2)C1C1C2C(C)(CCC(OCC)=C2)C2=CC1)=O NKCCRSFPYWZCQB-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 125000005245 nitryl group Chemical group [N+](=O)([O-])* 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510715996.9A CN105461776B (zh) | 2015-10-28 | 2015-10-28 | 一种黄体酮的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510715996.9A CN105461776B (zh) | 2015-10-28 | 2015-10-28 | 一种黄体酮的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105461776A CN105461776A (zh) | 2016-04-06 |
CN105461776B true CN105461776B (zh) | 2017-04-12 |
Family
ID=55599983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510715996.9A Active CN105461776B (zh) | 2015-10-28 | 2015-10-28 | 一种黄体酮的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105461776B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3475464A (en) * | 1966-11-07 | 1969-10-28 | Syntex Corp | Process for the preparation of steroids and novel intermediates thereof |
CN103848879A (zh) * | 2013-11-28 | 2014-06-11 | 湖南科源生物制品有限公司 | 一种以1,4-雄烯二酮为原料制备黄体酮的方法 |
CN104098640A (zh) * | 2014-08-06 | 2014-10-15 | 赵云现 | 黄体酮的制备方法 |
CN104262442A (zh) * | 2014-10-10 | 2015-01-07 | 湖南科瑞生物科技有限公司 | 黄体酮的制备方法 |
-
2015
- 2015-10-28 CN CN201510715996.9A patent/CN105461776B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3475464A (en) * | 1966-11-07 | 1969-10-28 | Syntex Corp | Process for the preparation of steroids and novel intermediates thereof |
CN103848879A (zh) * | 2013-11-28 | 2014-06-11 | 湖南科源生物制品有限公司 | 一种以1,4-雄烯二酮为原料制备黄体酮的方法 |
CN104098640A (zh) * | 2014-08-06 | 2014-10-15 | 赵云现 | 黄体酮的制备方法 |
CN104262442A (zh) * | 2014-10-10 | 2015-01-07 | 湖南科瑞生物科技有限公司 | 黄体酮的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105461776A (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102516345B (zh) | 醋酸乌利司他及其关键中间体的制备方法 | |
CN102898495B (zh) | 醋酸阿比特龙酯的制备方法 | |
CN102134265B (zh) | 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法 | |
TW548277B (en) | Orally active androgens | |
CN102875629A (zh) | 醋酸乌利司他的合成方法 | |
TW200404079A (en) | Processes to prepare EPLERENONE | |
CN105461776B (zh) | 一种黄体酮的合成方法 | |
CN104098640A (zh) | 黄体酮的制备方法 | |
CN106928047A (zh) | 一种降血脂药物环丙贝特的合成方法 | |
CN102952169A (zh) | 6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮合成方法 | |
CN105593236A (zh) | 用于合成醋酸乌利司他及其4′-乙酰基类似物的工业化方法 | |
CN105017365A (zh) | 一种合成6-甲基-17α-羟基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法 | |
CN106518944A (zh) | 甲基泼尼松的制备方法 | |
CN104945458B (zh) | 一种黄体酮的合成方法 | |
CN105399790B (zh) | 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 | |
CN113735932A (zh) | 一种制备坎利酮的脱氢方法 | |
CN105732757A (zh) | 黄体酮的制备方法 | |
CN103130862A (zh) | 醋酸乌利司他关键中间体3,20-双(亚乙二氧基)-19-去甲孕甾5,9-二烯-17-醇的新合成方法 | |
CN104558091B (zh) | 一种醋酸阿比特龙的合成方法 | |
CN108047296B (zh) | 一种倍他米松中间体的制备方法 | |
CN103319558B (zh) | 甾体化合物及其制备方法和用途 | |
ES2336439T3 (es) | Proceso para la preparacion de 7-alfa-metilesteroides. | |
CN112047842A (zh) | 一种1,4-二烯烃类化合物及其制备方法与应用 | |
CN102850420B (zh) | 一种表雌三醇的合成方法 | |
CN111349137A (zh) | 一种绿色合成醋酸乌利司他中间体及醋酸乌利司他的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic method of progesterone Effective date of registration: 20200928 Granted publication date: 20170412 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230131 Granted publication date: 20170412 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthesis method of progesterone Granted publication date: 20170412 Pledgee: Industrial and Commercial Bank of China Limited Shaoyang Beita Branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980006163 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |